Factors contributing to conductance and outcome of specific immunotherapy: Data from the German National Health Interview and Examination Survey 1998

European Journal of Public Health

Volumn 17, Issue 3, 2007, Pages 278-284

  Hommers, Leif ^a   Ellert, Ute ^a   Scheidt Nave, Christa ^a   Langen, Ute ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Allergies; German National Health Interview and Examination Survey 1998; Specific immunotherapy

Indexed keywords

ADULT; AGED; ALLERGIC DISEASE; ALLERGIC RHINITIS; ARTICLE; CONFIDENCE INTERVAL; FEMALE; FOOD ALLERGY; GERMANY; HEALTH SURVEY; HUMAN; IMMUNOTHERAPY; INTERVIEW; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEURODERMATITIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SENSITIZATION; SOCIAL STATUS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGED; ASTHMA; CROSS-SECTIONAL STUDIES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; HYPERSENSITIVITY; INTERVIEWS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; SMOKING; SOCIOECONOMIC FACTORS;

EID: 34548417487     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckl241     Document Type: Article

References (15)

1. ECRHS. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (drafted by Burney S et al.). Eur Respir J 1996;9:687-95.
2. Hermann-Kunz E. Häufigkeit allergischer Krankheiten in Ost- und Westdeutschland (Frequency of allergic diseases in East and West Germany). Das Gesundheitswesen 1999; 61 Sonderheft 2:S100-5.
3. Weißbuch Allergie in Deutschland (Whitebook Allergy in Germany). Dtsch. Ges. f. Allergologie u. klin. Immunologie (DGAI), Ärzteverband Dtsch. Allergologen (ÄDA), Dtsch. Akad. f. Allergologie u. Umweltmedizin (DAAU) (eds). München: Urban and Vogel, 2000.
4. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database of Systematic Reviews 2003. Issue 4. Art. No.: CD001186. doi:10.1002/14651858.CD001186.
5. Polzehl D, Keck T, Riechelmann H. Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma. Laryngorhinotologie 2003;82(4):272-80.
6. BSACI. Report of a BSACI Working Party. Position paper on allergen immunotherapy. Clin Exp Allergy 1993;23(Suppl 3):1-44.
7. WHO/IUIS Working Group Report. Current status of allergen immunotherapy. Lancet 1989;1:259-61.
8. EAACI. The European Academy of Allergology and Clinical Immunology. Position paper: immunotherapy. Allergy 1993;48(14 Suppl):9-35.
9. Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. WHO position paper. Allergy 1998;53 (44;Suppl.):1-42.
10. Li J, Lockey R, Bernstein L, Portnoy J, Nicklas R. Allergen immunotherapy: a practice parameter. Ann Allergy, Asthma Immunol 2003; 90(Suppl 1):1-40.
11. Specific immunotherapy (hyposensitisation) for IgE-mediated allergic diseases. Allergo J 2006;15:56-74.
12. Thefeld W, Stolzenberg H, Bellach B-M. Bundes-Gesundheitssurvey: response, Zusammensetzung der Teilnehmer und non-responder-analyse (German National Health Interview and Examination Survey: Response, structure of the participants and non-responder analysis). Das Gesundheitswesen 1999;61(Sonderheft):S57-61.
13. Kurth B-M, Ellert U. The SF-36 questionnaire and its usefulness in population studies - results of the German Health Interview and Examination Survey 1998. Soz - Präventivmed 2002;47:266-77.
14. Ross R, Nelson H, Finegold I. Effectiveness of specific immunotherapy in the treatment of asthma: a meta analysis of prospective, randomized, double-blind, placebo-controlled studies. Clin Therap 2000;22(3): 329-41.
15. Vona I. Immunotherapy for house dust allergy. Clin Otolaryngol 1997;22:52-6.